Key facts
- This page summarizes Nadav Besner's Form 4 filing for OTR Acquisition Corp..
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 20 May 2022, 16:36.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Conversion of derivative security
Other
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Conversion of derivative security
Additional SEC filing notes
Section 16 status
Nadav Besner is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
As described in the issuer's registration statement on Form S-1 (File No. 333-248093) (the "Registration Statement") under the heading "Description of Securities," the shares of Class B common stock, par value $0.0001 per share ("Class B Stock"), automatically convert into shares of Class A common stock, par value $0.0001 per share ("Class A Stock"), at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and certain anti-dilution rights and has no expiration date.
Footnote F2
(Continued from Footnote 1) On May 19, 2022, the issuer consummated its initial business combination (the "Business Combination") with Comera Life Sciences Holdings, Inc.. ("Holdco"), a Delaware corporation. In connection with the Business Combination, each share of Class B Stock converted into Class A Stock.
Footnote F3
In connection with the Business Combination, the reporting person exchanged its Class A Shares for 5,000 fully paid and non-assessable shares of common stock, par value U.S. $0.0001 per share, of Holdco Common Stock.